Advertisement

Sterile Empty Vials

[14 July 2014]

Products Affected - Description

Empty Sterilized Vials, Fresenius Kabi
10 mL, 25 count (NDC 63323-0001-10)
30 mL, 25 count (NDC 63323-0001-30)

Reason for the Shortage

  • Hospira states the shortage is due to manufacturing delays.
  • Fresenius Kabi (formerly APP) reduced production of sterile empty vials to permit increased production of drug products affected by critical shortages.
  • Sterile empty vials may be available from medical supply distributors.

Available Products

Sterile Empty Vials, Hospira
10 mL, 50 count (List #05816-11)
30 mL, 50 count (List #05816-31)
 
Empty Sterilized Vials, Fresenius Kabi
5 mL, 25 count (NDC 63323-0001-05)
100 mL, 40 count (NDC 63323-0001-00)

Estimated Resupply Dates

Fresenius Kabi has 10 mL and 30 mL sterile empty vials on back order and the company cannot estimate a release date.

Related Shortages

Updated

July 14, 2014; May 9, 2014; March 28, 2014; January 27, 2014; December 10, 2013; October 28, 2013; August 26, 2013; July 18, 2013; May 31, 2013; May 9,2013; April 11, 2013; February 26, 2013; February 1, 2013; January 9, 2013; December 5, 2012; November 15, 2012; October 24, 2012; October 11, 2012; October 5, 2012; September 5, 2012; July 10, 2012; June 5, 2012; May 2, 2012; April 23, 2012; April 16, 2012; March 12, 2012; March 5, 2012; February 22, 2012; January 27, 2012; January 26, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement